Junjiang Sun

Junjiang Sun is a Research Assistant Professor in the Division of Chemical Biology and Medicinal Chemistry (CBMC) at the University of North Carolina at Chapel Hill School of Medicine. His research focuses on developing gene therapy approaches for hemophilia and associated joint diseases, particularly using adeno-associated virus (AAV) vectors to express bypassing agents like activated coagulation factors V and IX. This work extends to applications in rheumatoid arthritis (RA) and osteoarthritis (OA), leveraging gene therapy platforms to address inflammatory and degenerative joint conditions.

No scientific awards, grants, or student advisees are explicitly listed in the provided information. His affiliations include the CBMC division within the UNC School of Medicine, with email contact available at junjiang_sun@med.unc.edu.